Canine distemper virus (CDV) infection induces multifocal demyelination in the 25 central nervous system (CNS). It is thought that the resident macrophages of the 26 CNS, the microglia, as well as invading monocytes associated with the inflammatory 27 reaction may play a central role in the demyelinating process. To evaluate changes in 28 peripheral monocytes in CDV infection their immunophenotype was characterized by 29 flow cytometry during the course of an experimental CDV infection in dogs. The 30 highest number of CDV infected monocytes was found in dogs developing 31 demyelinating lesions. In CD18, CD45, CD44, and CD14 neither up-nor down-32 regulation was observed. Marked up-regulation occurred in a number of surface 33 molecules including CD1c, B7-1 and B7-2, MHC I, and CD11b. Peak expression was 34 found at 4 to 5 weeks post infection (PI), regardless of clinical outcome. All these 35 molecules play an important role in the host's immune response, notably antigen 36 presentation and cell adhesion. These results demonstrate that CDV infection in vivo 37 may enhance several macrophage functions. This could lead to more effective 38 clearance of the virus but may also increase demyelination through a bystander 39 effect in animals that accumulated significant amounts of CDV in the CNS. 40 41
INTRODUCTION 44
Canine distemper virus (CDV) is a single-stranded RNA morbillivirus belonging to the 45 family of Paramyxoviridae (Pringle, 1999) . In the acute phase of the disease CDV 46 infection induces multifocal demyelination in the central nervous system (CNS) 47 against a background of a systemic disease with severe immunosuppression and 48 lymphoid depletion (Vandevelde et al., 1982; Krakowka et al., 1985; Greene and 49 Appel, 2006) . The pathogenesis of CDV-associated immunosuppression remains 50 unclear (Greene and Appel, 2006) . Replication of virus in the immunocompetent cells 51 leads to disturbed function or lymphocytic apoptosis (Wunschmann et al., 2000; 52 Kumagai et al., 2004; Schobesberger et al., 2005) whereby CD4 + cells are more 53 affected than CD8 + cells (Tipold et al., 2001) . In the subacute and chronic stage of 54 the infection, an antiviral immune response is initiated and is associated with 55 additional inflammatory damage to the white matter (Vandevelde and Zurbriggen, 56 2005) . The contributing factors in the pathogenesis of demyelination in distemper 57 include viral replication in astrocytes (Vandevelde et al., 1982) , restricted infection of 58 oligodendrocytes (Zurbriggen et al., 1998) , down-regulation of myelin gene 59 transcription (Graber et al., 1995) , dysregulation of cytokines, metalloproteinases and 60 their inhibitors (Markus et al., 2002; Gröters et al., 2005) and the intrathecal antiviral 61 immune response (Vandevelde and Zurbriggen, 2005) . There is little doubt that the 62 microglial/macrophage compartment plays a pivotal role on the effector side of the 63 demyelinating process (Vandevelde and Zurbriggen 2005) . As monocytes and 64 microglia are both members of the macrophage-lineage they show cross-reactivity of 65 many surface markers (Dijkstra et al., 1985; Perry and Gordon, 1991; Flaris et al., 66 1993; Fedoroff, 1995; Stoll and Jander, 1999) , and upon activation similar effector 67 functions can be exerted (Graeber and Streit, 1990) . Microglial cells are activated in 68 distemper (Tipold et al., 2001 , Stein et al., 2004 , and show an up-regulation of MHC 69
Page 4 of 32 A c c e p t e d M a n u s c r i p t 4 II (Alldinger et al., 1996) and various other surface molecules (Stein et al., 2004) , as 70 well as enhanced secretion of reactive oxygen species (Stein et al., 2004) . In the 71 course of the inflammatory response in demyelinating lesions in distemper, 72 peripheral monocytes/macrophages invade the CNS, complementing the local 73 microglia. The central role of macrophages in myelin destruction was proposed by 74 earlier investigators in distemper (Wisniewsky, 1972) , and supported by in vitro 75 studies, showing ADCC in CDV-infected canine brain cell cultures (Griot-Wenk et al., 76 1991) . Not much is known about the effect of CDV on peripheral blood monocytes. In 77 contrast to the overt CDV-induced lymphopenia, monocyte numbers are not 78 significantly decreased and monocytosis is very rarely observed (McCullough et al., 79 1973; Tipold, 1996; Greene and Appel, 2006) . This might be due to minimal 80 replication of CDV in these cells (Von Messling et al., 2004) . Cultured macrophage 81 functions seemed not to be impaired and may even be enhanced as a result of CDV 82 infection (Brugger et al., 1992) . 83
The objective of the present study was to examine peripheral monocytes isolated 84 from experimentally CDV-infected dogs at various stages of the infection and to 85 characterize changes which may be relevant to the pathogenesis of demyelination. 86
87

MATERIAL AND METHODS 88
Animals 89
Twenty 5-6-months-old experimentally CDV-infected SPF Swiss-Beagle dogs, 10 90 males and 10 females from two litters were derived from a DNA vaccine study with 91 challenge infection with the virulent CDV-strain A75/17 (111/99/Berne/CH; Stein et al. 92 2004; experiment see Cherpillod et al., 2000) . All animals were regularly physically 93 and neurologically examined and rectal temperature was measured daily. Blood 94
Page 5 of 32 A c c e p t e d M a n u s c r i p t 5 samples for monocyte isolation were taken every 3-4 days. All dogs were euthanized 95 20-31 days post infection (PI). 96
All but one dog (no. 18) showed a bi-to triphasic febrile body temperature from three 97 days PI on (see Fig. 1 ) which was accompanied by lymphopenia in 13 dogs, and 98 clinical signs consistent with systemic CDV infection such as diarrhea, rhinitis, 99 conjunctivitis, coughing and weight loss. In six dogs the clinical signs resolved and 100 they showed no abnormalities at the time of euthanasia. The remaining 14 dogs 101 developed additional neurological signs indicating forebrain and/or brainstem lesions. 102
According to the clinical signs after remission of initial disease the dogs were 103 assigned to three examination groups. 104
Group I comprised seven dogs with no clinical signs (dog nos. 3, 4, 6, 9, 11, 16, 18 ; 105 see Tab. 1). These dogs showed the lowest mean body temperature in the course of 106 the disease and after initial fever no second phase of elevated body temperature 107 occurred (see Fig. 1 ). No lesions were found on histopathological examination of the 108 CNS. The six dogs of group II displayed mild clinical signs such as conjunctivitis and 109 diarrhea (dog nos. 5, 8, 10, 12, 13, 14 ; see Tab. 1), their mean body temperature 110 was slightly higher than that of group I (see Fig. 1 ). There were no lesions in their 111 brains demonstrated by histopathology. Seven dogs confined to group III showed 112 severe clinical signs (dog nos. 1, 2, 7, 15, 17, 19, 20; see Tab. 1) . The dogs of group 113 III showed highest rectal temperatures in the course of the CDV infection (see Fig. 1 ) 114 with a triphasic elevation of the temperature and severe neurological signs. 115
Histopathological examination of the latter dogs showed active lesions: the brain of MAbs used for immunophenotypic analyses were either specific for dog cell surface 130 markers or cross-reacting with them. Monoclonal mouse antibodies directed against 131
CD11b, CD18, CD1c, B7-1 (CD80), B7-2 (CD86), CD3, CD4, CD8, and CD21 were 132 provided by Prof. Peter F. Moore, University of Davis, USA. MAbs against CD11b, 133 CD18, CD4, CD8, CD21 and MHC class I were characterized at the first 134 international canine leukocyte antigen workshop (Cobbold and Metcalfe, 1994) . The 135 following primary antibodies were purchased: mAb directed against CD45 136 (conjugated with biotin), CD44 (both rat mAb, Serotec, Eching, Germany), MHC class 137 I (mouse mAb, VMRD, Inc. Pullman, USA) and CD14 conjugated with R-PE (mouse 138 mAb, Dako, Glostrup, Denmark). The clones of the monoclonal antibodies are 139 summarized in Table 2 . The murine mAb D110 was prepared from cell culture 140 supernatant (Bollo et al., 1986) and used for detection of an epitope of the CDV 141 nucleocapsid protein which is resistant to tissue fixation and embedding procedures. Germany), R-PE conjugated F(ab´)2 fragment rabbit anti-rat (rar-PE) and 147 streptavidine conjugated fluorescein-isothiocyanate (FITC, both from Serotec, 148
Eching, Germany) for flow cytometry. 149 150
Isolation of peripheral blood mononuclear cells (PBMCs) and flow cytometry 151
Peripheral blood was examined once or twice weekly until euthanasia. Approximately 152 5 ml of blood was collected by venipuncture into heparinized tubes and subjected to 153 discontinuous density gradient centrifugation according to Wunderli and Felsburg 154 (1989) modified by Somberg et al. (1992) . Briefly, Pancoll (density 1.077; Cytogen, 155
Ober-Moerlen, Germany) and Histopaque (density 1.119; Sigma, Deisenhofen, 156
Germany) were used and centrifuged at 400 x g for 20 min at room temperature. 157
After centrifugation PBMCs accumulated as a white cell-layer at the interphase 158 between plasma and Pancoll. Following two washing steps with PBS the supernatant 159 was discarded and cells were available for further examination. Monocyte and 160 lymphocyte subsets were differentiated as two cell populations by their differing size 161 (forward scatter, FSC) and complexity (side scatter, SSC), and monocytes were 162 selectively examined after gating this population in flow cytometry (see Fig. 5A ). Low 163 percentages of the gated cells for the expression of CD3, CD8, CD21 and CD4 164 served to exclude contamination with lymphocytes. 165
Monocytes were examined every third to forth day in the course of the CDV infection. 166
They were stained as previously described for lymphocyte subsets (Tipold et al., 167 1999) . After Fc-receptor blockade with 10 mg/ml of human IgG, primary antibodies 168 were incubated for 30 min at 4°C and washed twice with Hanks´ buffered saline 169 (Sigma, Deisenhofen, Germany). Secondary antibodies conjugated either with FITC Page 8 of 32 A c c e p t e d M a n u s c r i p t 8 (CD45), rar-PE (CD44), or gam-PE (all other mAbs) were diluted 1:100, added and 171 incubation was continued for 30 min. Following two washing steps, cells were 172 resuspended in FACS flow solution and analysed immediately after staining without 173 fixation with a FACSCalibur™ using the Cell-Quest  -Software (both: BD Biosciences, 174
Heidelberg, Germany). Negative control samples were stained with the secondary 175 antibodies only. Cell viability was assessed by propidium iodide exclusion. Analysis 176 gates were adjusted to not exceed 2% positive staining with negative controls (see 177 
Detection of CDV in monocytes 180
CDV detection in monocytes was performed as previously described (Cherpillod et 181 al., 2000) . Briefly, monocytes were fixed with 2% paraformaldehyde for 20 min at 182 4°C. After two washing steps with PBS, cells were resuspended in 50µl PBS 183 containing 0.03% Saponin (Merck, Hannover, Germany) for cell permeabilisation. 184 
Detection of CDV in canine monocytes 193
In all but three dogs of group I and II with no or mild clinical signs CDV nucleocapsid 194 protein was detected in only 0 -5.5% of the monocytes on day 6 PI. A few days later The results are depicted in Figures 2 and 3 . 215
The percentage of monocytes expressing CD18, CD11b, CD45, CD44, B7-2 216 (CD86), and MHC I did not show a significant change in the course of the infection in 217 any of the examination groups (data not shown). CD14 showed an initial increase 218 and remained constant during the experiment; group III had generally lower 219 percentages of expression than the other two groups (Fig. 2 ). CD1c and B7-1 220 (CD80) were expressed in a continuously increasing percentage of positive cells for 221
Page 10 of 32 A c c e p t e d M a n u s c r i p t 10 all three examination groups during the course of the CDV infection peaking towards 222 the end of the fourth week PI followed by a decline during the last week of the 223 experiment (see Fig. 2A + B ). CD1c and CD14 were found in a generally higher 224 percentage of monocytes in group I (mean values of the whole examination period 225 are given; CD14  = 74.7%; CD1c  = 63.4%) and group II (CD14  = 72.9%; CD1c  226 = 57.4%) compared to group III (CD14  = 53.9%; CD1c  = 46.7%; see Fig. 2A + C) . 227
Expression intensity of CD1c also steadily increased in all groups reaching its 228 maximum at the end of the fourth week PI (see Fig. 3A ). Likewise, the surface 229 molecules, CD11b, B7-2 (CD86), and MHC I showed an up-regulated expression 230 intensity peaking at the end of the third week PI, followed by a gradual down-231 regulation in all three examination groups except for MHC I, which remained high 232 until the end of the experiment (see Fig. 3B-D) . For CD18, CD45, CD44, CD14, and 233 B7-1 (CD80) no up-or down-regulated expression intensity was measured in any 234 examination group. 235 236
Correlation between up-regulation of surface antigens and body temperature 237
Peak levels of MHC I, CD11b, B7-2 (CD86), and CD1c expression intensity were 238 preceded by or concurrent with elevations of body temperature in several animals. 239
This correlation was particularly striking for B7-2 which was detected in almost all of 240 the dogs in each examination group (see Fig. 4 ). The differential haemogram in distemper characteristically reveals a lymphopenia 248 eventually in combination with a leukopenia (Greene and Appel, 2006) . In contrast, 249 monocyte numbers are hardly affected and may even be increased in distemper 250 (McCullough et al., 1973; Appel, 1987; Tipold 1996; Greene and Appel, 2006) . One 251 study showed a mild transient decrease of CD14-positive monocytes early in the 252 course of experimental CDV infection (Schobesberger et al., 2005) . The present 253 study confirms that the absolute monocyte numbers may oscillate during the course 254 of CDV infection but never reach subcritical values neither in dogs with severe 255 clinical signs and widespread lesions in the CNS (group III) nor in dogs with no or 256 mild clinical signs without alteration of the CNS (group I and group II). 257
In the present study the percentage of expressing monocytes as well as the 258 expression intensity of nine different surface molecules were examined in the course 259 of a CDV challenge infection. While a somewhat lower proportion of monocytes 260 expressed CD1c and CD14 in dogs of group III as compared to group I and group II 261 (see Fig. 2A+C, Table 3 ), the frequency of expression of other surface markers was 262 not reduced. On the contrary, CD11b, B7-1 (CD80), B7-2 (CD86), and MHC I were 263 enhanced in all dogs (see Table 3 ), including those with severe clinical signs and 264 demyelinating lesions in the CNS (group III). This finding is consistent with the 265 inflammatory demyelination is initiated (Vandevelde and Zurbriggen, 2005) . 328
In conclusion, our study has shown that CDV infection markedly alters the expression 329 of surface molecules of peripheral blood monocytes generally in the sense of an up-330 regulation. Up-regulation of certain markers may favour entry of these cells in the 331 CNS and/or enhance their effector functions. Thus this study supports the notion that 332 macrophages, either derived from microglia or peripheral monocytes, play a central 333 role in the demyelinating process in CDV infection. 
